LogoFDA 510(k) Search
Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K233160
    Device Name
    NeuTrace EP Mapping System v.2.1
    Manufacturer
    Anumana, Inc
    Date Cleared
    2023-11-25

    (59 days)

    Product Code
    DQK
    Regulation Number
    870.1425
    Type
    Traditional
    Panel
    Cardiovascular (CV)
    Reference & Predicate Devices
    K202066,K133916
    Why did this record match?
    Device Name :

    NeuTrace EP Mapping System v.2.1

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The NeuTrace EP Mapping System v2.1 is indicated for catheter-based cardiac electrophysiological (EP) procedures. The NeuTrace EP Mapping System v2.1 provides information about the electrical activity of the heart and about catheter location during the procedure. The system can be used on patients who are eligible for a conventional electrophysiological procedure in the right atrium. The system has no special contraindications.

    Device Description

    The NeuTrace EP Mapping System v2.1 (NeuTrace System) is an advanced 3D electroanatomical mapping (EAM) and analysis system capable of:

    • Displaying catheter location during electrophysiology mapping procedures
    • Displaving 3D images of cardiac structures
    • Displaying cardiac activity signals as waveforms (ECGs and EGMs)
    • Displaying derived voltage and time metric overlays over cardiac models -. including Peak-to-Peak Voltage, Local Activation Time (LAT), Fractionation, and Minimum dV/dt

    The NeuTrace System comprises the following software and hardware components:

    • NeuTrace Workstation
    • Window field generator
    • System control unit
    • System interface unit
    • Interface switches and connection cables
    • NeuTrace Software Application v2.1
    • NeuTrace Streaming Application Software v2.0 0

    The NeuTrace System is used together with compatible recording systems and compatible catheters listed in the device labeling to perform its intended use to support electrophysiology procedures in the right atrium.

    AI/ML Overview

    Here's an analysis of the provided text, extracting information related to the acceptance criteria and the study proving the device meets those criteria:

    Device Name: NeuTrace EP Mapping System v.2.1
    Product Code: DQK
    Regulatory Class: Class II

    1. Table of Acceptance Criteria and Reported Device Performance

    The document doesn't explicitly present a formal "acceptance criteria" table with pre-defined thresholds. Instead, it describes performance metrics that were measured and the results achieved, which implicitly serve as the "met criteria." The "Comments" column indicates whether the observed performance meets or aligns with expectations for substantial equivalence.

    Performance MetricAcceptance Criteria (Implicit)Reported Device PerformanceComments
    Ground-truth AccuracyExpected to be low (e.g.,
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1